5 years ago

Dose-adjusted Plasma Concentrations of Sublingual Buprenorphine are Lower During than After Pregnancy

Caritis, S.N., Tarter, R., Zhang, H., English, D., Bastian, J.R., Rothenberger, S., Chen, H., Venkataramanan, R.
(Am J Obstet Gynecol. 2017;216(1):64.e1–64.e7) Buprenorphine is increasingly used in pregnant women with opioid use disorders, as it has recently been associated with less severe neonatal complications and comparable efficacy as methadone. Currently, dosing of buprenorphine for pregnant women is based on recommendations for nonpregnant patients; however, drug absorption and metabolism can be impacted by pregnancy. This study examined the pharmacokinetic properties of sublingual buprenorphine in pregnant women and the postpartum period.
You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.